Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA approves J&J's Cypher stent for use in smaller blood vessels
Yahoo/AP
Monday, September 21, 2009 - 4:48pm
tags:
FDA, JNJ, stents, Cypher
Drugmaker Merck seeks EU approval for $41B acquisition of Schering-Plough, expects ruling soon
Yahoo/AP
Monday, September 21, 2009 - 4:47pm
tags:
Merck, EU, Europe, Schering Plough, M&A
GlaxoSmithKline bans political donations, alters spending rules on doctor training, consulting
Yahoo/AP
Monday, September 21, 2009 - 10:52am
tags:
GSK, physicians, physician payments
Biotech News Bytes: Neuralstem, Questcor, Valeant, Impax
Seeking Alpha
Monday, September 21, 2009 - 10:48am
tags:
Neuralstem, Questcor Pharmaceuticals, Valeant Pharmaceuticals, Impax
Perrigo buys KV Pharma filing for generic acne gel
Reuters
Monday, September 21, 2009 - 10:35am
tags:
KV Pharmaceutical, Perrigo Company, acne
Alzheimer’s, Dementia Rise Faster Than Expected, Report Says
Bloomberg
Monday, September 21, 2009 - 10:19am
tags:
Alzheimer's disease, dementia
Arena's Lorcaserin Has Safety Edge
Yahoo/Zacks.com
Monday, September 21, 2009 - 10:10am
tags:
Arena Pharmaceuticals, lorcaserin, obesity, Vivus, Orexigen
AstraZeneca gets rights to 2 Nektar pain drug candidates in deal valued at about $1.12B
Yahoo/AP
Monday, September 21, 2009 - 9:57am
tags:
AstraZeneca, Nektar
Biogen Idec Makes Bid for Facet for $14.50 a Share
Bloomberg
Monday, September 21, 2009 - 9:56am
tags:
Biogen Idec, Facet Biotech, M&A
Eli Lilly cancer drug shows 'significant" benefit
Marketwatch
Monday, September 21, 2009 - 9:53am
tags:
Eli Lilly, cancer, Alimta, lung cancer
Grassley to the FDA: Are Statins Really Safe?
Businessweek
Monday, September 21, 2009 - 9:28am
tags:
FDA, statins, Grassley, side effects
BioCryst Flu Drug Order Below Expectations
TheStreet.com
Monday, September 21, 2009 - 9:23am
tags:
Flu, swine flu, H1N1, Biocryst, GSK, peramivir
Three Life Science Companies Line Up for IPOs
Seeking Alpha
Monday, September 21, 2009 - 9:21am
tags:
IPOs, Talecris, Anthera, Omeros
Amgen reports results of trial of cancer treatment
Marketwatch
Monday, September 21, 2009 - 9:20am
tags:
Amgen, cancer, denosumab, Zometa, Novartis
King Announces Commercial Availability of EMBEDA(TM)
Yahoo
Monday, September 21, 2009 - 9:19am
tags:
King, chronic pain, Embeda, opiods
China Biotech Week in Review: SFDA Approvals All Around
Seeking Alpha
Monday, September 21, 2009 - 9:17am
tags:
China, SFDA, Abbott Laboratories, Genzyme, China Aoxing, China Medical Technologies
Merck eyes larger Merial
FT.com
Monday, September 21, 2009 - 9:16am
tags:
Merck, Merial, Sanofi, M&A, veterinary medicine
Bayer, Onyx’s Nexavar Drug Helps Slow Breast Cancer Progression
Bloomberg
Monday, September 21, 2009 - 9:15am
tags:
Nexavar, Bayer, ONYX Pharmaceuticals, breast cancer
In Lilly's pipeline: Profit or Peril?
Indianapolis Star, IN
Sunday, September 20, 2009 - 12:34pm
tags:
Eli Lilly, pipelines
Sun Pharma to file 30 applications for generic drugs in US
Economic Times, India
Sunday, September 20, 2009 - 12:33pm
tags:
Sun Pharma, India

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.